{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:10:51Z","timestamp":1785435051874,"version":"3.56.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T00:00:00Z","timestamp":1515110400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"None"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s12098-017-2586-8","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T02:37:41Z","timestamp":1515119861000},"page":"124-131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Global Polio Eradication \u2013 Way Ahead"],"prefix":"10.1007","volume":"85","author":[{"given":"Sunil","family":"Bahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland W","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrun","family":"Roesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Zaffran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,5]]},"reference":[{"key":"2586_CR1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.15585\/mmwr.mm6518a4","volume":"65","author":"M Morales","year":"2016","unstructured":"Morales M, Tangermann RH, Wassilak SG. Progress toward polio eradication - Worldwide, 2015-2016. MMWR Morb Mortal Wkly Rep. 2016;65:470\u20133.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2586_CR2","unstructured":"World Health Assembly. Global eradication of poliomyelitis by the year 2000: resolution 41.28. Geneva. Switzerland: World Health Organization; 1988."},{"key":"2586_CR3","unstructured":"Centers for Disease Control and Prevention (CDC). Progress toward global poliomyelitis eradication. MMWR Morb Mortal Wkly Rep. 2001;50:320-2, 331."},{"key":"2586_CR4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.coviro.2012.02.006","volume":"2","author":"O Kew","year":"2012","unstructured":"Kew O. Reaching the last one per cent: progress and challenges in global polio eradication. Curr Opin Virol. 2012;2:188\u201398.","journal-title":"Curr Opin Virol"},{"key":"2586_CR5","first-page":"1482","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","unstructured":"Centers for Disease Control and Prevention (CDC). Progress toward poliomyelitis eradication---India, January 2010--September 2011. MMWR Morb Mortal Wkly Rep. 2011;60:1482\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2586_CR6","unstructured":"McGirk T. Polio\u2019s surprising comeback: Taliban Assassins Target Pakistan's Polio Vaccinators. National Geographic, 3rd March 2015."},{"key":"2586_CR7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.15585\/mmwr.mm6607a2","volume":"66","author":"C Nnadi","year":"2017","unstructured":"Nnadi C, Damisa E, Esapa L, et al. Continued endemic wild poliovirus transmission in security-compromised areas - Nigeria, 2016. MMWR Morb Mortal Wkly Rep. 2017;66:190\u20133.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2586_CR8","volume-title":"Polio Eradication & Endgame Strategic Plan 2013\u20132018","author":"Global Polio Eradication Initiative","year":"2013","unstructured":"Global Polio Eradication Initiative. Polio Eradication & Endgame Strategic Plan 2013\u20132018. Geneva, Switzerland: World Health Organization; 2013. (WHO\/POLIO\/13.02)"},{"key":"2586_CR9","doi-asserted-by":"crossref","first-page":"934","DOI":"10.15585\/mmwr.mm6535a3","volume":"65","author":"LM Hampton","year":"2016","unstructured":"Hampton LM, Farrell M, Ramirez-Gonzalez A, et al. Immunization Systems Management Group of the Global Polio Eradication Initiative. Cessation of trivalent oral poliovirus vaccine and introduction of inactivated poliovirus vaccine - worldwide, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:934\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2586_CR10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1586\/14760584.2016.1140041","volume":"15","author":"J Garon","year":"2016","unstructured":"Garon J, Seib K, Orenstein WA, et al. Polio endgame: the global switch from tOPV to bOPV. Expert Rev Vaccines. 2016;15:693\u2013708.","journal-title":"Expert Rev Vaccines"},{"key":"2586_CR11","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.15585\/mmwr.mm6552a9","volume":"65","author":"S Bahl","year":"2017","unstructured":"Bahl S, Hampton LM, Bhatnagar P, et al. Notes from the field: detection of Sabin-like type 2 poliovirus from sewage after global cessation of trivalent oral poliovirus vaccine - Hyderabad and Ahmedabad, India, August-September 2016. MMWR Morb Mortal Wkly Rep. 2017;65:1493\u20134.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2586_CR12","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.vaccine.2017.03.008","volume":"35","author":"A Anand","year":"2017","unstructured":"Anand A, Molodecky NA, Pallansch MA, Sutter RW. Immunogenicity of poliovirus type 2 following two intradermal fractional doses of inactivated poliovirus vaccine: a novel dose sparing immunization schedule. Vaccine. 2017;35:2993\u20138.","journal-title":"Vaccine"},{"key":"2586_CR13","doi-asserted-by":"crossref","unstructured":"Okayasu H, Sein C, Chang-Blanc D, et al. Intradermal administration of fractional doses of inactivated poliovirus vaccine: a dose sparing option for polio immunization. J Infect Dis. 2017;216:S161\u20137.","DOI":"10.1093\/infdis\/jix038"},{"key":"2586_CR14","unstructured":"Global Commission for the Certification of Poliomyelitis Eradication. 14th Meeting of the Global Commission for the Certification of Poliomyelitis Eradication (GCC) Bali, Indonesia, 20\u201321 2015: Summary of findings, decisions and recommendations. Geneva, Switzerland: World Health Organization; 2015. p. 1\u201311."},{"key":"2586_CR15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","volume":"59","author":"OM Kew","year":"2005","unstructured":"Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Ann Rev Microbiol. 2005;59:587\u2013635.","journal-title":"Ann Rev Microbiol"},{"key":"2586_CR16","doi-asserted-by":"crossref","unstructured":"Sutter RO, Cochi K, Aylward S. Poliovirus vaccine - live. Vaccines, 6th ed. In: Plotkin SA, Orenstein WA, editors. Philadelphia: WB Saunders; 2008. p. 631\u201385.","DOI":"10.1016\/B978-1-4160-3611-1.50030-1"},{"key":"2586_CR17","first-page":"335","volume":"215","author":"MS Collett","year":"2017","unstructured":"Collett MS, Hincks JR, Benschop K, et al. Antiviral activity of pocapavir in a randomized, blinded, placebo-controlled human oral poliovirus vaccine challenge model. J Infect Dis. 2017;215:335\u201343.","journal-title":"J Infect Dis"},{"key":"2586_CR18","doi-asserted-by":"crossref","first-page":"S447","DOI":"10.1093\/infdis\/jiu043","volume":"210","author":"MA McKinlay","year":"2014","unstructured":"McKinlay MA, Collett MS, Hincks JR, et al. Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradication. J Infect Dis. 2014;210:S447\u201353.","journal-title":"J Infect Dis"},{"key":"2586_CR19","first-page":"333","volume":"215","author":"RW Sutter","year":"2017","unstructured":"Sutter RW, Modlin JF, Zaffran M. Completing polio eradication: the case for antiviral drugs. J Infect Dis. 2017;215:333\u20134.","journal-title":"J Infect Dis"},{"key":"2586_CR20","doi-asserted-by":"crossref","first-page":"S286","DOI":"10.1093\/infdis\/175.Supplement_1.S286","volume":"175","author":"WR Dowdle","year":"1997","unstructured":"Dowdle WR, Birmingham ME. The biologic principles of poliovirus eradication. J Infect Dis. 1997;175:S286\u201392.","journal-title":"J Infect Dis"},{"key":"2586_CR21","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.1093\/infdis\/175.Supplement_1.S281","volume":"175","author":"FC Robbins","year":"1997","unstructured":"Robbins FC, de Quadros CA. Certification of the eradication of indigenous transmission of wild poliovirus in the Americas. J Infect Dis. 1997;175:S281\u20135.","journal-title":"J Infect Dis"},{"key":"2586_CR22","unstructured":"Centers for Disease Control and Prevention (CDC). Certification of poliomyelitis eradication--Western Pacific Region, October 2000. MMWR Morb Mortal Wkly Rep. 2001;50:1\u20133."},{"key":"2586_CR23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2807\/esm.07.05.00369-en","volume":"7","author":"The WHO European Region declared free of polio","year":"2002","unstructured":"The WHO European Region declared free of polio. Euro Surveill. 2002;7:76\u20137.","journal-title":"Euro Surveill"},{"key":"2586_CR24","first-page":"941","volume":"63","author":"S Bahl","year":"2014","unstructured":"Bahl S, Kumar R, Menabde N, et al. Polio-free certification and lessons learned--South-East Asia region, March 2014. MMWR Morb Mortal Wkly Rep. 2014;63:941\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2586_CR25","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1128\/JCM.36.10.2893-2899.1998","volume":"36","author":"OM Kew","year":"1998","unstructured":"Kew OM, Sutter RW, Nottay BK, et al. Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol. 1998;36:2893\u20139.","journal-title":"J Clin Microbiol"},{"key":"2586_CR26","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.vaccine.2015.01.018","volume":"33","author":"J Guo","year":"2015","unstructured":"Guo J, Bolivar-Wagers S, Srinivas N, Holubar M, Maldonado Y. Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication. Vaccine. 2015;33:1235\u201342.","journal-title":"Vaccine"},{"key":"2586_CR27","unstructured":"Expanded Programme on Immunization. Report of the 1st Meeting of the Global Commission for the Certification of the Eradication of Poliomyelitis Geneva, Switzerland, 16-17 1995. Geneva, Switzerland: World Health Organization; 1995 (WHO\/EPI\/GEN\/95.6)."},{"key":"2586_CR28","unstructured":"Panacea Biotec Ltd. Panacea Biotec introduces World\u2019s first fully liquid hexavalent combination vaccine EasySix\u2122 for Six Preventable Diseases. Available at: www.panacea-biotec.com\/press_releases\/PR29032017.pdf . Accessed on 19 September 2017."},{"key":"2586_CR29","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1056\/NEJMra020025","volume":"346","author":"JG Breman","year":"2002","unstructured":"Breman JG, Henderson DA. Diagnosis and management of smallpox. N Engl J Med. 2002;346:1300\u20138.","journal-title":"N Engl J Med"},{"key":"2586_CR30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005114","volume":"11","author":"G Dunn","year":"2015","unstructured":"Dunn G, Klapsa D, Wilton T, Stone L, Minor PD, Martin J. Twenty-eight years of poliovirus replication in an immunodeficient individual: impact on the global polio eradication initiative. PLoS Pathog. 2015;11:e1005114.","journal-title":"PLoS Pathog"},{"key":"2586_CR31","first-page":"561","volume":"91","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Meeting of the Strategic Advisory Group of Experts on immunization, October 2016 \u2013 conclusions and recommendations. Wkly Epidemiol Rec. 2016;91:561\u201382.","journal-title":"Wkly Epidemiol Rec"},{"key":"2586_CR32","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa1202541","volume":"368","author":"S Resik","year":"2013","unstructured":"Resik S, Tejeda A, Sutter RW, et al. Priming after a fractional dose of inactivated poliovirus vaccine. N Engl J Med. 2013;368:416\u201324.","journal-title":"N Engl J Med"},{"key":"2586_CR33","first-page":"301","volume":"92","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Meeting of the Strategic Advisory Group of Experts on immunization, April 2017 \u2013 conclusions and recommendations. Wkly Epidemiol Rec. 2017;92:301\u201320.","journal-title":"Wkly Epidemiol Rec"},{"key":"2586_CR34","unstructured":"Centers for Disease Control and Prevention. Polio Endgame and Legacy. Available at: https:\/\/www.cdc.gov\/polio\/plan\/ . Accessed on 19 April 2017."},{"key":"2586_CR35","unstructured":"World Health Organization. WHO global action plan to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of oral polio vaccine use \u2013 GAPIII. Geneva, Switzerland: World Health Organization; 2015 (WHO\/POLIO\/15.05)."},{"key":"2586_CR36","doi-asserted-by":"crossref","unstructured":"Adeyemi OO, Nicol C, Stonehouse NJ, Rowlands DJ. Increasing type 1 poliovirus capsid stability by thermal selection. J Virol. 2017;91. pii: e01586\u201316.","DOI":"10.1128\/JVI.01586-16"},{"key":"2586_CR37","unstructured":"Stony Brook University. Stable packaging cell lines for the same and efficient manufacture of vaccines against polio and other viruses. Available at: http:\/\/www.stonybrook.edu\/research\/otlir\/technologies\/Therapeutics\/R-8166.pdf . Accessed on 4 April 2017."}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12098-017-2586-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-017-2586-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-017-2586-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T07:11:47Z","timestamp":1603609907000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12098-017-2586-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,5]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["2586"],"URL":"https:\/\/doi.org\/10.1007\/s12098-017-2586-8","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,5]]}}}